Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Journal subject
Affiliation country
Publication year range
1.
Intensive Care Med ; 43(4): 509-518, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28271321

ABSTRACT

PURPOSE: The aim of the study was to describe the characteristics of cirrhotic patients with candidemia and intra-abdominal candidiasis (IAC) and to evaluate the risk factors associated with 30-day mortality. METHODS: A multicenter multinational retrospective study including all consecutive episodes of candidemia and IAC in adult patients with liver cirrhosis in 14 European hospitals during the period 2011-2013 was performed. RESULTS: A total of 241 episodes (169 candidemia, 72 IAC) were included. Most Candida infections were acquired in hospital (208, 86.3%), mainly in the intensive care unit (ICU) (121, 50.2%). At clinical presentation, fever was seen in 60.6% of episodes (146/241) and septic shock in 34.9% (84/241). C. albicans was the most common species (found in 131 episodes, 54.4%), followed by C. glabrata (35, 14.5%) and C. parapsilosis (34, 14.1%). Overall, the 30-day mortality was 35.3%. Multivariable analysis identified candidemia (OR 2.2, 95% CI 1.2-4.5) and septic shock (OR 3.2, 95% CI 1.7-6) as independent factors associated with 30-day mortality. Adequate antifungal treatment (OR 0.4, 95% CI 0.3-0.9) was associated with survival benefit. CONCLUSIONS: A shift towards increasing prevalence of C. glabrata and C. parapsilosis species in patients with liver disease was documented. Candidemia and IAC were associated with significant mortality in cirrhotic patients. Thirty-day mortality was associated with candidemia and severe clinical presentation, whereas adequate antifungal treatment improved the prognosis.


Subject(s)
Antifungal Agents/therapeutic use , Candidemia/mortality , Cross Infection/mortality , Liver Cirrhosis/complications , Shock, Septic/mortality , Aged , Candida/isolation & purification , Candidemia/complications , Candidemia/drug therapy , Comorbidity , Cross Infection/drug therapy , Cross Infection/microbiology , Echinocandins/therapeutic use , Europe/epidemiology , Female , Humans , Intensive Care Units , Intraabdominal Infections/drug therapy , Intraabdominal Infections/etiology , Male , Middle Aged , Multivariate Analysis , Retrospective Studies , Risk Factors , Shock, Septic/drug therapy , Shock, Septic/microbiology , Time Factors
2.
Future Microbiol ; 10(1): 15-20, 2015.
Article in English | MEDLINE | ID: mdl-25598334

ABSTRACT

AIM: To assess epidemiological features of patients for which a consultation by the infectious diseases consultation team was required, and the rate of clinical advice that led to resource-saving advice (R-SA): discontinuation of inappropriate therapy or prophylaxis, de-escalation and switch from parenteral to oral therapy. MATERIALS & METHODS: An infectious diseases consultation team was implemented in a 1100-bed university hospital in Italy. RESULTS: The most frequent infections for which an infectious diseases consultancy was required were pneumonia, bloodstream infections (17% by Candida) and urinary tract infections. In 828 patients (41.4%), interventions with the possibility of R-SA were suggested. CONCLUSION: Resource-saving advices were possible in 41% of cases. Recent surgery, having a central venous catheter, bloodstream, abdominal, surgical site or bone and joint infections were correlated to a higher probability of receiving R-SA.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Communicable Diseases , Cross Infection/epidemiology , Hospitals, University/economics , Referral and Consultation/economics , Candidiasis/drug therapy , Candidiasis/epidemiology , Cross Infection/drug therapy , Drug Utilization , Female , Humans , Italy/epidemiology , Male , Pneumonia/drug therapy , Pneumonia/epidemiology , Risk Factors , Sepsis/epidemiology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL